Skip to main content
. 2021 May 31;12:639315. doi: 10.3389/fneur.2021.639315

Table 2.

Safety (adverse events).

Pts No of tx Route of administration Intervals (months) Adverse events Severity Outcome
001 3 1—IV+IT
2—IV+IT
3—IV+IT
0
6
12
1—none
2—none
3—none
002 3 1—IV+IT
2—IV+IT
3—IV+IT
0
12
24
1—headache, fever
2—headache
3—none
1—mild 2—moderate 1—resolved, 24 h
2—resolved, 3 days
003 4 1—IV+IT
2—IV+IT
3—IV
4—IV
0
12
24
36
1—fever, headache, general weakness
2—headache, general weakness
3—none
4—none
1—mild
2—mild
1—resolved, 3 days
2—resolved, 3 days
004 8 1—IV+IT
2—IV+IT
3—IV+IT
4—IV+IT
5—IV+IT
6—IV+IT
7—IV
8—IV+IT
0
6
12
18
24
30
36
42
1—headache, back pain
2—none
3—headache
4—back pain
5—none
6—none
7—none
8—headache
1—moderate

3—mild
4—mild



8—mild
1—resolved, 2 days

3—resolved, 24 h
4—resolved, 3 days



8—resolved 2 days
005 8 1—IV + IT
2—IV
3—IV
4—IV
5—IV
6—IV
7—IV
8—IV
0
6
12
18
24
30
36
42
1—none
2—none
3—none
4—none
5—none
6—none
7—none
8—none
006 6 1—IV + IT
2—IV + IT
3—IV + IT
4—IV
5—IV + IT
6—IV + IT
0
6
12
18
24
36
1—neck rigidity, headache, back pain, leukocytosis
2—headache, back pain
3—none
4—none
5—headache
6—headache
1—severe


2—moderate


5—mild
6—mild
1—resolved, 3 days


2—resolved, 4 days


5—resolved 24 h
6—resolved, 24 h
007 6 1—IV + IT
2—IV
3—IV
4—IV
5—IV
6—IV + IT
0
12
18
24
36
42
1—fever
2—none
3—none
4—none
5—none
6—headache
1—moderate




6—mild
1—resolved 24 h




6—resolved 24 h
008 3 1—IV + IT
2—IV
3—IV
0
12
24
1—none
2—none
3—none
009 4 1—IV + IT
2—IV + IT
3—IV + IT
4—IT
0
6
18
24
1—headache
2—fever, headache
3—none
4—none
1—mild 2—moderate 1—resolved 24 h
2—resolved 24 h
010 3 1—IV + IT
2—IV
3—IV
0
12
24
1—headache
2—none
3—none
1—mild 1—resolved 24 h
011 2 1—IV + IT
2—IV
0
12
1—none
2—none
012 5 1—IV + IT
2—IV + IT
3—IV + IT
4—IV + IT
5—IV + IT
0
6
18
30
42
1—none
2—fever
3—none
4—headache
5—none

2—mild

4—mild

2—resolved 24 h

4—resolved 3 days
013 5 1—IV + IT
2—IV + IT
3—IV + IT
4—IV + IT
5—IT
0
6
12
24
36
1—urinary retention, fever, headache
2—none
3—none
4—none
5—none
1—moderate 1—resolved, 24 h
014 2 1—IV + IT
2—IV
0
12
1—none
2—none
015 3 1—IV + IT
2—IV + IT
3—IV + IT
0
12
24
1—none
2—headache
3—none

2—mild

2—resolved 24 h
016 3 1—IV + IT
2—IV + IT
3—IV
0
12
24
1—none
2—none
3—none
017 2 1—IV + IT
2—IV + IT
0
6
1—fever
2—headache
1—mild
2—mild
1—resolved 24 h
2—resolved 24 h
018 2 1—IV + IT
2—IV
0
6
1—none
2—none
019 2 1—IV + IT
2—IT
0
6
1—none
2—none
020 6 1—IV + IT
2—IV + IT
3—IV
4—IV + IT
5—IV + IT
6—IV + IT
0
6
18
24
36
42
1—none
2—back pain
3—none
4—headache, fever
5—none
6—headache

2—mild

4—mild

6—mild

2—resolved, 3 days

4—resolved 24 h

6—resolved 24 h
021 3 1—IV + IT
2—IV + IT
3—IV + IT
0
12
24
1—none
2—none
3—none
022 2 1—IV + IT
2—IV + IT
0
6
1—none
2—none
023 2 1—IV + IT
2—IV + IT
0
12
1—back pain
2—back pain, sciatic pain
1—mild
2—moderate
1—resolved, 3 days
2—resolved 7 days
024 2 1—IV + IT
2—IV
0
6
1—none
2—none
Total: 89 IV = 86 injections
IT = 64 injections
IT + IV: 61
41 adverse events 1 severe,
13 of moderate severity, others: mild
All resolved
between 1 and 7 days

Tx = treatments with MSC; Pts = patients.